KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Is Labman on the money?

  1. mrdaxbrown
    20 Posts.
    lightbulb Created with Sketch. 22
    clock Created with Sketch.
    29/12/22
    10:53
    Post #: 65467848
    Is LabMan on the money ?

    LabManYesterday 7:44:36 PM


    $KZIA Inherent resistance to the alkylating agents temozolomide and lomustine, in MGMT-unmethylated glioblastoma, renders futile control comparison in the pAX Global Coalition study. Effectively there is no control mechanism for adaptive studies in the AGILE study. Clarification of company announcements, at a future time will conclude efficacy in the unmethylated pAX study.

    KZA Price at posting: 7.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.